Ghoshroy K B, Zhu W, Sampson N S
Department of Chemistry, State University of New York, Stony Brook 11794-3400, USA.
Biochemistry. 1997 May 20;36(20):6133-40. doi: 10.1021/bi962190p.
Dye leakage experiments were undertaken to investigate the membrane disruption properties of cholesterol oxidase. Inspection of the X-ray crystal structures of cholesterol oxidase suggested that an active-site "lid" opens in order to bind substrate [Li, J., Vrielink, A., Brick, P., & Blow, D. M. (1993) Biochemistry 32, 11507-11515]. We tested whether the interaction of the putative active-site lid with the membrane was sufficiently disruptive of the membrane structure to cause leakage or lysis of the cell membrane. Vesicles (100 nm) composed of egg phosphatidylcholine, 2-palmitoyl-3-oleoyl-1-sn-phosphatidylethanolamine, and 2-palmitoyl-3-oleoyl-1-sn-phosphatidylcholine were used in this study to mimic biomembranes. To separate the effects of membrane binding from conversion of cholesterol to cholest-4-en-3-one, the active-site mutant E361Q was utilized. In the reaction catalyzed by E361Q, isomerization of the cholest-5-en-3-one intermediate is suppressed and cholest-5-en-3-one is the major product isolated. Furthermore, E361Q produces cholest-5-en-3-one 20-fold more slowly than wild type produces cholest-4-en-3-one from cholesterol. Wild-type and E361Q cholesterol oxidases bind to vesicles with an apparent K(D) of approximately 25 microM, as measured by quenching of intrinsic tryptophan fluorescence, irrespective of headgroup size and cholesterol content. Membrane disruption was measured by leakage of the encapsulated marker carboxyfluorescein. Leakage was observed with cholesterol-containing vesicles and wild-type enzyme only; the rate of leakage was dependent on the rate of cholest-4-en-3-one production. E361Q did not induce membrane disruption, regardless of vesicle type tested. Thus, binding of cholesterol oxidase to the membrane and partitioning of cholesterol into the active site does not sufficiently perturb the bilayer to cause leakage of vesicle contents. Formation of the product cholest-4-en-3-one, however, does increase membrane permeability. Expansion of the lipid bilayer upon conversion of cholesterol to cholest-4-en-3-one is the likely cause of this increased permeability.
进行了染料泄漏实验以研究胆固醇氧化酶的膜破坏特性。对胆固醇氧化酶的X射线晶体结构检查表明,活性位点“盖子”打开以结合底物[Li, J., Vrielink, A., Brick, P., & Blow, D. M. (1993) Biochemistry 32, 11507 - 11515]。我们测试了假定的活性位点盖子与膜的相互作用是否足以破坏膜结构,从而导致细胞膜泄漏或裂解。本研究使用由鸡蛋磷脂酰胆碱、2 - 棕榈酰 - 3 - 油酰 - 1 - 甘油磷脂酰乙醇胺和2 - 棕榈酰 - 3 - 油酰 - 1 - 甘油磷脂酰胆碱组成的囊泡(100纳米)来模拟生物膜。为了区分膜结合的影响与胆固醇向胆甾 - 4 - 烯 - 3 - 酮的转化,使用了活性位点突变体E361Q。在由E361Q催化的反应中,胆甾 - 5 - 烯 - 3 - 酮中间体的异构化受到抑制,胆甾 - 5 - 烯 - 3 - 酮是分离得到的主要产物。此外,E3Q1从胆固醇生成胆甾 - 5 - 烯 - 3 - 酮的速度比野生型生成胆甾 - 4 - 烯 - 3 - 酮的速度慢20倍。野生型和E361Q胆固醇氧化酶与囊泡结合,通过内在色氨酸荧光猝灭测量,其表观解离常数(K(D))约为25微摩尔,与头部基团大小和胆固醇含量无关。通过封装的标记物羧基荧光素的泄漏来测量膜破坏。仅在含胆固醇的囊泡和野生型酶中观察到泄漏;泄漏速率取决于胆甾 - 4 - 烯 - 3 - 酮的生成速率。无论测试的囊泡类型如何,E361Q均未诱导膜破坏。因此,胆固醇氧化酶与膜的结合以及胆固醇向活性位点的分配不足以扰乱双层膜,从而导致囊泡内容物泄漏。然而,产物胆甾 - 4 - 烯 - 3 - 酮的形成确实会增加膜通透性。胆固醇转化为胆甾 - 4 - 烯 - 3 - 酮时脂质双层的膨胀可能是这种通透性增加的原因。